Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Morepen Laboratories Ltd buy melinda

Start price
?0.23
11.09.17 / 50%
Target price
€0.30
14.11.17
Performance (%)
11.90%
End price
€0.26
14.11.17
Summary
This prediction ended on 14.11.17 with a price of €0.26. The prediction had a final performance of 11.90%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Morepen Laboratories Ltd - - - -
iShares Core DAX® -0.268% 5.471% 14.271% 19.027%
iShares Nasdaq 100 1.854% 7.851% 35.426% 58.415%
iShares Nikkei 225® 0.284% 1.729% 9.943% 7.045%
iShares S&P 500 1.178% 5.269% 27.989% 49.400%

Comments by melinda for this prediction

In the thread Morepen Laboratories Ltd diskutieren
Prediction Buy
Perf. (%) 11.90%
Target price 0.298
Change
Ends at 14.11.17

LABOR



Morepen Laboratories of India

11. September (Reuters) - Morepen Laboratories Ltd: Juni - Quartal Nettogewinn von 19,6 Millionen Rupien verglichen mit einem Gewinn von 29,8 Millionen Rupien vor einem Jahr. Die Gesamterträge der Juni - Quartal 1,24 Milliarden Rupien gegen 1,21 Milliarden Rupien vor einem Jahr.



Prediction Buy
Perf. (%) 11.90%
Target price 0.298
Change
Ends at 14.11.17

(Vom Mitglied beendet)